Photo via Semafor

Novo to partner with Anthropic on drug discovery efforts

Read the original at Semafor ↗
Cite

Ruberry, B. (2026, September 17). Novo to partner with Anthropic on drug discovery efforts. Semafor. https://www.semafor.com/article/09/17/2026/novo-to-partner-with-anthropic-on-drug-discovery-efforts

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Semafor · collected 2026-09-17 · by Brendan Ruberry

Quick Summary

Danish pharmaceutical company Novo Nordisk plans to collaborate with Anthropic to enhance its drug discovery processes through artificial intelligence technology. This move comes as Novo Nordisk seeks to regain market share it has lost in recent months, evidenced by a 20% drop in its stock prices over the past year. While other competitors like Lilly, Merck, and Roche have also invested in AI for productivity improvements and clinical trial design, Novo Nordisk aims to be at the forefront of using AI directly in discovering new drugs. The company is rebranding itself as simply "Novo" starting this week as part of its broader strategic shift.
Written by AI on 2026-09-18, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

Danish drugmaker Novo Nordisk announced it will partner with AI research company Anthropic to accelerate its drug development efforts. This move comes after the company's stock price fell by 20% over the past year, amid competition from rivals such as Lilly, Merck, and Roche, which have also invested in artificial intelligence but primarily for improving workplace efficiency and clinical trial design rather than discovering new drugs. Novo Nordisk hopes that AI will aid in bioscience research and help it regain its market position lost to competitors, particularly since its Ozempic injectable became synonymous with GLP-1 treatments. To adapt to these changes, the company has also initiated a cultural shift within its organization.

Written for “Novo And Anthropic Partnership” on 2026-11-01, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Novo And Anthropic Partnership
Technology · 1 article(s) covering the same event.

Compared with similar articles

This article reads unscored and hedges 0% of its claims. Each row says how that neighbour differs.
Anthropic CEO Dario Amodei: "For too long the industry lied" about AI risks Different event
CBS News
Hedges 4 of 37 claims Outlet record 66/100
“The articles describe different events related to Anthropic but occurring on distinct dates and involving separate topics: one is about Amodei's comments on AI risks, while the other is about a partnership with Novo Nordisk for drug discovery.”
Meet Myreen Ahsan, the Friendswood 8th-grader who screened over 10 million drug-like molecules Different event
Times of India
Hedges 3 of 34 claims Outlet record 59/100
“The articles describe different events: one about an eighth-grade student's research project using AI to screen molecules for treating frontotemporal dementia, and another about a pharmaceutical company partnering with Anthropic to use AI in drug discovery efforts.”
Anthropic partners with IT company Accenture to evaluate frontier AI models Different event
Washington Examiner
Hedges 0 of 24 claims Outlet record 70/100
“The articles describe different partnerships involving Anthropic: one with Novo Nordisk for drug discovery and another with Accenture for evaluating AI models.”
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
3
sentences that state something as happening or true
Uncertain
0%
0 of 3 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
60/100
Semafor's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Technology
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-18 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Semafor · 1393 article(s) · 1 correction(s) detected
Running correction rate · 1 correction(s)
2026-10-16
LA's 'Selling Sunset' real estate agency opens a Dubai office

Who wrote this

Brendan Ruberry
141 article(s) here · 1 carrying a prediction
🔮 Though oil prices retreated this week as Washington and Tehran pursued tentative diplomacy, refining capacity remains limited, and the White House has signaled it could resume strikes on Iran after midterms.
2026-10-29 · mixed framing · US economy grows faster than expected
🔮 Both Kyiv and Moscow praised US first lady Melania Trump for helping secure the truce in Oleshky, which some warned Russia would use for military resupply and propaganda efforts, as the conflict’s death toll mounts elsewhere.
2026-10-29 · assertive framing · Russia strikes Ukraine amid ceasefire in occupied Oleshky
🔮 Benjamin Netanyahu is now oddsmakers’ favorite to stay on as Israel’s prime minister in its next government, which could take weeks or months to form, as the broader region braced for a period of prolonged uncertainty.
2026-10-29 · mixed framing · Netanyahu becomes prediction markets' favorite to be next Israeli PM
🔮 “If it happens again around the US elections, the havoc would reach a whole new level.”
2026-10-29 · mixed framing · Investors eye Brazilian equities after election selloff
🔮 The projected results delivered a rebuke to Prime Minister Benjamin Netanyahu, whose coalition finished behind that of challenger Gadi Eisenkot, who has offered himself as a hawkish alternative to the scandal-dogged Netanyahu.
2026-10-27 · mixed framing · No clear winner in Israel's election, exit polls indicate
🔮 US gas prices are 40% higher than one year ago, driven by energy pressures resulting from the Iran war, which has spiked shipping costs and the price of many household items; the Federal Reserve is expected to hit pause on interest rates this week, but not for long, investors predicted.
2026-10-27 · assertive framing · US consumer confidence ticks up in October
🔮 Coming days before the Communist Party’s Fifth Plenum, the intervention may have helped “prop up the market,” a Chinese financial commentator said, but “it couldn’t prop up investors’ confidence.”
2026-10-27 · mixed framing · China's 'national team' state funds intervene amid market rout
🔮 Bolsonaro’s loss comes as the Trump administration’s “Donroe Doctrine” to reassert hegemony over Latin America is being tested elsewhere: The US is charting a path toward Venezuelan elections, but the return of the country’s popular opposition leader could complicate that process, analysts noted, risking hardliner backlash.
2026-10-27 · speculative framing · US offers visa to Brazil's Flávio Bolsonaro as he flees corruption charges
🔮 France’s far-right presidential favorite Marine Le Pen said new Ukraine funding before April elections would be a “democratic scandal,” as Ukraine hunkers down for winter: Kyiv has attempted to harden its grid as Moscow intensifies strikes on energy infrastructure, but delayed regulatory reforms have put it on the back foot.
2026-10-27 · assertive framing · EU lobbies G7 nations to increase Ukraine funding
🔮 Waiving tariffs on some Canadian agricultural products could presage similar efforts in Michigan and New Hampshire, where Republican candidates facing uphill election fights have spoken out against tariffs on Canada.
2026-10-25 · mixed framing · US to remove some Canadian tariffs ahead of elections
Also by Brendan Ruberry
Canada to take equity stake in AI firm
2026-10-29 · Semafor
Russia strikes Ukraine amid ceasefire in occupied Oleshky
2026-10-29 · Semafor
Alphabet loses $500 billion in market value
2026-10-29 · Semafor
Nvidia chief targeted in alleged spy plot
2026-10-29 · Semafor
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 141 articles by Brendan Ruberry →

Topics

Anthropic Danish Lilly Novo Novo Nordisk

Subjects

Novo ORG · 3× Novo Nordisk ORG · 2× Anthropic ORG · 1× Danish NORP · 1× Lilly PERSON · 1× Merck ORG · 1× Roche ORG · 1×

Narrative

Novo rivals Lilly, Merck, and Roche have all invested in AI, though it has largely been used to improve workplace productivity and design clinical trials, rather than discover new drugs. But researchers are bullish on AI’s use for bioscience, and Novo — having jumped out to a lead with its Ozempic injectable that became synonymous with GLP-1s — is playing catch up: Its shares have plunged 20% in the past year, prompting the firm to launch a culture shake-up.
framing: assertive · carried by 1 article(s) · first seen 2026-09-18
🔮 Danish drugmaker Novo Nordisk will partner with Anthropic in an effort to speed up drug development, as the one-time GLP-1 leader bets AI will help it reclaim lost market share.
2026-09-18 · Semafor
Novo to partner with Anthropic on drug discovery efforts · assertive framing

Claims (3 extracted, 0 hedged)

Danish drugmaker Novo Nordisk will partner with Anthropic in an effort to speed up drug development, as the one-time GLP-1 leader bets AI will help it reclaim lost market share. asserted
it → partner → share
Novo rivals Lilly, Merck, and Roche have all invested in AI, though it has largely been used to improve workplace productivity and design clinical trials, rather than discover new drugs. But researchers are bullish on AI’s use for bioscience, and Novo — having jumped out to a lead with its Ozempic injectable that became synonymous with GLP-1s — is playing catch up: Its shares have plunged 20% in the past year, prompting the firm to launch a culture shake-up. asserted
shares → invest → up
From this week, Novo Nordisk will henceforth be known simply as “Novo.” asserted
Nordisk → know → Novo
💬Give feedback
🕘History 🎫Support
Terms · Privacy · beta v2.0.0
Articles to 1 Nov 2026